Sector | Healthcare | Compare with Sector peers |
Industry | Pharmaceuticals & Drugs | Compare with Industry peers |
Website | http://www.sakarhealthcare.com | |
Market Cap | 770.93 Cr. | |
Enterprise Value(EV) | 839.15 Cr. | 2023-09 |
Financial Indicators | ||
---|---|---|
Earnings per share (EPS) | 5.73 | Trailing Twelve Months Ending 2023-12 |
Price-Earning Ratio (PE) | 61.81 | Trailing Twelve Months Ending 2023-12 |
Industry PE | 41.74 | Trailing Twelve Months Ending 2023-12 |
Book Value / Share | 118.28 | Trailing Twelve Months Ending 2023-12 |
Price to Book Value | 3.00 | Calculated using Price: 354.45 |
Dividend Yield | 0.00 | Period Ending 2023-03 |
No. of Shares Subscribed | 2.17 Cr. | 21,749,910 Shares |
FaceValue | 10 | |
About Sakar Healthcare Ltd. | ||
The company is an Indian pharmaceutical company engaged in the manufacturing and marketing of its own pharmaceutical formulations for domestic and international markets. Its Product domestic sales are generally exported by third party. It also undertakes contract manufacturing of formulations for pharmaceutical companies based in India. It manufactures and markets pharmaceutical formulations relating to analgesics, antielminthics, anti coagulants, anti malarial, anti spasmodics, antianemics, antibiotics, anti-emetics, anti-histamines, bronchodilators, corticosteroids, cough and cold preparations, multivitamins, etc. |
1 Day |
|
-3.84% |
1 Week |
|
-4.78% |
1 Month |
|
-3.08% |
3 Month |
|
-19.82% |
6 Month |
|
+1.16% |
1 Year |
|
+65.55% |
2 Year |
|
+151.20% |
5 Year |
|
+457.31% |
10 Year |
|
4 years | 2020-03 | 2021-03 | 2022-03 | 2023-03 | |
Return on Equity (%) | 11.83 | 11.88 | 13.44 | 8.48 | |
Return on Capital Employed (%) | 14.79 | 13.16 | 12.09 | 8.95 | |
Return on Assets (%) | 8.36 | 7.3 | 6.81 | 4.22 |
Particulars | 5 years | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. | 2023-09* Rs. Cr. |
Shh. Funds | 81 | 98 | 127 | 173 | 237 | |
Non Curr. Liab. | 20 | 46 | 94 | 109 | 74 | |
Curr. Liab. | 14 | 33 | 47 | 54 | 47 | |
Minority Int. | ||||||
Equity & Liab. | 115 | 178 | 268 | 336 | 357 | |
Non Curr. Assets | 93 | 144 | 218 | 280 | 300 | |
Curr. Assets | 22 | 34 | 50 | 56 | 57 | |
Misc. Exp. not W/O | ||||||
Total Assets | 115 | 178 | 268 | 336 | 357 |
Particulars | 5 years | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. | 2023-12 Rs. Cr. TTM |
Net Sales | 83 | 95 | 128 | 133 | 151 | |
Other Income | 2 | 1 | 2 | 5 | 4 | |
Total Income | 85 | 96 | 130 | 138 | 155 | |
Total Expenditure | -63 | -72 | -99 | -100 | -116 | |
PBIDT | 22 | 24 | 32 | 38 | 39 | |
Interest | -2 | -2 | -3 | -6 | -8 | |
Depreciation | -7 | -8 | -10 | -15 | -17 | |
Taxation | -3 | -3 | -4 | -4 | -3 | |
Exceptional Items | 0 | |||||
PAT | 10 | 11 | 15 | 13 | 12 | |
Minority Interest | ||||||
Share Associate | ||||||
Other Related Items | ||||||
Consolidated Net Profit | 10 | 11 | 15 | 13 | 12 | |
Adjusted EPS | 6 | 7 | 9 | 7 | 6 |
Particulars | 4 years | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. |
Cash Fr. Operatn. | 19 | 15 | 36 | 33 | |
Cash Fr. Inv. | -22 | -47 | -90 | -74 | |
Cash Fr. Finan. | 3 | 32 | 55 | 41 | |
Net Change | 0 | 0 | 0 | 0 | |
Cash & Cash Eqvt | 0 | 0 | 0 | 0 |
Fri, 12 Apr 2024
Disclosure under SEBI Takeover Regulations Sanjay S. Shah has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. |
Fri, 05 Apr 2024
Updates Sakar Healthcare Limited has informed the Exchange regarding 'Certificate under Regulation 74 (5) of the SEBI (Depositories and Participants) Regulations, 2018 for the Quarter Ended 31st March 2024'. |
Fri, 29 Mar 2024
Trading Window-XBRL SAKAR HEALTHCARE LIMITED has informed the Exchange about Closure of Trading Window |
Thu, 25 Apr 2024 |
Higher Delivery Quantity |
Higher Trade Quantity |
Higher Trade and Delivery Quantity |
Opening at High |
Closing Below Previous Low |